Latest News and Press Releases
Want to stay updated on the latest news?
-
MELVILLE, N.Y., Feb. 13, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a late stage clinical regenerative medicine innovator...
-
Dublin, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The "Protein Labeling - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's...
-
Dublin, Feb. 06, 2026 (GLOBE NEWSWIRE) -- The "Biobanking Market Report 2025-2035" report has been added to ResearchAndMarkets.com's offering.This report will prove invaluable to leading firms...
-
Pluristyx and Solesis launch ready-to-use kit combining high-quality pluripotent cells and mRNA technology with proprietary transfection technology
-
DETROIT, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Michigan Integrative Health Stem Cells, a leading provider of stem cell therapy and regenerative medicine in Shelby Township, Michigan, announces the...
-
Detroit, MI, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Michigan Integrative Health Stem Cells, a leading provider of stem cell therapy and regenerative medicine in Shelby Township, Michigan, announces the...
-
GÖTTINGEN, Germany, Feb. 02, 2026 (GLOBE NEWSWIRE) -- German biotech company Repairon GmbH announced the formation of its fully owned subsidiary, Repairon USA, Inc., to enable the expansion of...
-
TORONTO and HAIFA, Israel, Jan. 30, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) today announced changes to its board of...
-
South San Francisco, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- The California Institute for Regenerative Medicine (CIRM) has approved a new funding program to accelerate therapies for rare diseases,...
-
Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains a...